PrecisionFDA
Brain Cancer Predictive Modeling and Biomarker Discovery Challenge


An estimated 86,970 new cases of primary brain and other central nervous system tumors are expected to be diagnosed in the US in 2019. Brain tumors comprise a particularly deadly subset of all cancers due to limited treatment options and the high cost of care. Clinical investigators at Georgetown University are seeking to advance precision medicine techniques for the prognosis and treatment of brain tumors through the identification of novel multi-omics biomarkers. In support of this goal, precisionFDA and the Georgetown Lombardi Comprehensive Cancer Center and The Innovation Center for Biomedical Informatics at Georgetown University Medical Center (Georgetown-ICBI) are launching the Brain Cancer Predictive Modeling and Biomarker Discovery Challenge! This challenge will ask participants to develop machine learning and/or artificial intelligence models to identify biomarkers and predict patient outcomes using gene expression, DNA copy number, and clinical data.


  • Starts
    2019-11-01 16:00:00 UTC
  • Ends
    2020-02-02 04:59:59 UTC

3 months remaining


In order to participate in this challenge, please login. If you don't have a PrecisionFDA account, please submit an access request to join and engage in the community!